{"doc_id": "33068293", "type of study": "Therapy", "title": "", "abstract": "The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia.\nThis study aimed to investigate the value of high-flow nasal cannula (HNFC) oxygen therapy in treating patients with severe novel coronavirus pneumonia (COVID-19).\nThe clinical data of 22 patients with severe COVID-19 were collected.\nThe heart rate (HR), respiratory rate (RR) and oxygenation index (PO2 /FiO2 ) at 0, 6, 24 and 72\u00a0hours after treatment were compared between the HFNC oxygen therapy group and the conventional oxygen therapy (COT) group.\nIn addition, the white blood cell (WBC) count, lymphocyte (L) count, C-reactive protein (CRP) and procalcitonin (PCT) were compared before and at 72\u00a0hours after oxygen therapy treatment.\nThe differences at 0\u00a0hours between the two groups were not statistically significant.\nCompared with COT group,in the HFNC oxygen therapy group, HR, RR and PaO2 /FiO2 were better at 6\u00a0hours after treatment, PaO2 /FiO2 was better at 24 and 72\u00a0hours.\nAfter 72\u00a0hours, L and CRP had improved in the HFNC oxygen therapy group compared with the COT group, but the differences in WBC and PCT were not statistically significant.\nThe length of stay in the intensive care unit (ICU) and the total length of hospitalization was shorter in the HFNC oxygen therapy group than in the COT group.\nCompared with COT, early application of HFNC oxygen therapy in patients with severe COVID-19 can improve oxygenation and RR, and HFNC oxygen therapy can improve the infection indexes of patients and reduce the length of stay in the ICU of patients.\nTherefore, it has high clinical application value.\n\u00a9 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.\n", "Evidence Map": {"Enrollment": [{"term": "novel coronavirus pneumonia", "negation": "affirmed", "UMLS": {}, "start": 64, "end": 91}, {"term": "severe novel coronavirus", "negation": "affirmed", "UMLS": {}, "start": 119, "end": 143}, {"term": "severe COVID-19", "negation": "affirmed", "UMLS": {}, "start": 38, "end": 53}, {"term": "severe COVID-19", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 93}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia .", "Evidence Elements": {"Participant": [{"term": "novel coronavirus pneumonia", "negation": "affirmed", "UMLS": {}, "start": 64, "end": 91}], "Intervention": [{"term": "high-flow nasal cannula oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 13, "end": 51, "has_procedure": [{"text": "high flow nasal cannula oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 38}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "OBJECTIVE", "Text": "This study aimed to investigate the value of high-flow nasal cannula ( HNFC ) oxygen therapy in treating patients with severe novel coronavirus pneumonia ( COVID-19 ) .", "Evidence Elements": {"Participant": [{"term": "severe novel coronavirus", "negation": "affirmed", "UMLS": {}, "start": 119, "end": 143}], "Intervention": [{"term": "high-flow nasal cannula ( HNFC ) oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 45, "end": 92, "has_procedure": [{"text": "high flow nasal cannula oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 38}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The clinical data of 22 patients with severe COVID-19 were collected .", "Evidence Elements": {"Participant": [{"term": "severe COVID-19", "negation": "affirmed", "UMLS": {}, "start": 38, "end": 53}], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The heart rate ( HR ) , respiratory rate ( RR ) and oxygenation index ( PO2 / FiO2 ) at 0 , 6 , 24 and 72 hours after treatment were compared between the HFNC oxygen therapy group and the conventional oxygen therapy ( COT ) group .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "HFNC oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 154, "end": 173, "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Outcome": [{"term": "heart rate ( HR )", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 21}, {"term": "respiratory rate ( RR )", "negation": "affirmed", "UMLS": {}, "start": 24, "end": 47}, {"term": "oxygenation index (", "negation": "affirmed", "UMLS": {}, "start": 52, "end": 71}, {"term": "FiO2 )", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 84}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "In addition , the white blood cell ( WBC ) count , lymphocyte ( L ) count , C-reactive protein ( CRP ) and procalcitonin ( PCT ) were compared before and at 72 hours after oxygen therapy treatment .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "white blood cell ( WBC ) count", "negation": "affirmed", "UMLS": {}, "start": 18, "end": 48}, {"term": "lymphocyte ( L ) count", "negation": "affirmed", "UMLS": {}, "start": 51, "end": 73}, {"term": "C-reactive protein ( CRP )", "negation": "affirmed", "UMLS": {}, "start": 76, "end": 102}, {"term": "procalcitonin ( PCT )", "negation": "affirmed", "UMLS": {}, "start": 107, "end": 128}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "The differences at 0 hours between the two groups were not statistically significant .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "two groups", "negation": "affirmed", "UMLS": {}, "start": 39, "end": 49, "has_relation": "N/A"}], "Outcome": [{"term": "differences at 0 hours", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 26}], "Observation": [{"term": "statistically significant", "negation": "negated", "UMLS": {}, "start": 59, "end": 84}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "two groups", "has_relation": "N/A"}, "Observation": "statistically significant", "Outcome": "differences at 0 hours", "Count": ""}]}, {"Section": "RESULTS", "Text": "Compared with COT group , in the HFNC oxygen therapy group , HR , RR and PaO2 / FiO2 were better at 6 hours after treatment , PaO2 / FiO2 was better at 24 and 72 hours .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "COT", "negation": "affirmed", "UMLS": {}, "start": 14, "end": 17, "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}, {"term": "HFNC oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 52, "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Outcome": [{"term": "HR", "negation": "affirmed", "UMLS": {}, "start": 61, "end": 63}, {"term": "RR", "negation": "affirmed", "UMLS": {}, "start": 66, "end": 68}, {"term": "FiO2", "negation": "affirmed", "UMLS": {}, "start": 80, "end": 84}, {"term": "FiO2", "negation": "affirmed", "UMLS": {}, "start": 80, "end": 84}], "Observation": [{"term": "better", "negation": "affirmed", "UMLS": {}, "start": 90, "end": 96}, {"term": "better", "negation": "affirmed", "UMLS": {}, "start": 90, "end": 96}], "Count": []}, "Evidence Propositions": [{"Intervention": [{"term": "COT", "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}, {"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Observation": "better", "Outcome": "HR", "Count": ""}, {"Intervention": [{"term": "COT", "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}, {"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Observation": "better", "Outcome": "RR", "Count": ""}, {"Intervention": [{"term": "COT", "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}, {"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Observation": "better", "Outcome": "FiO2", "Count": ""}, {"Intervention": [], "Observation": "better", "Outcome": "FiO2", "Count": ""}]}, {"Section": "RESULTS", "Text": "After 72 hours , L and CRP had improved in the HFNC oxygen therapy group compared with the COT group , but the differences in WBC and PCT were not statistically significant .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "HFNC oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 47, "end": 66, "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}, {"term": "COT", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 94, "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}], "Outcome": [{"term": "L and CRP", "negation": "affirmed", "UMLS": {}, "start": 17, "end": 26}, {"term": "differences", "negation": "affirmed", "UMLS": {}, "start": 111, "end": 122}, {"term": "WBC and PCT", "negation": "affirmed", "UMLS": {}, "start": 126, "end": 137}], "Observation": [{"term": "improved", "negation": "affirmed", "UMLS": {}, "start": 31, "end": 39}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}, "Observation": "improved", "Outcome": "L and CRP", "Count": ""}, {"Intervention": {"term": "COT", "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}, "Observation": "improved", "Outcome": "L and CRP", "Count": ""}]}, {"Section": "RESULTS", "Text": "The length of stay in the intensive care unit ( ICU ) and the total length of hospitalization was shorter in the HFNC oxygen therapy group than in the COT group .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "HFNC oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 113, "end": 132, "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Outcome": [{"term": "length of stay in the intensive care unit ( ICU )", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 53}, {"term": "total length of hospitalization", "negation": "affirmed", "UMLS": {}, "start": 62, "end": 93}], "Observation": [{"term": "shorter", "negation": "affirmed", "UMLS": {}, "start": 98, "end": 105}], "Count": []}, "Evidence Propositions": [{"Intervention": [{"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Observation": "shorter", "Outcome": "length of stay in the intensive care unit ( ICU )", "Count": ""}, {"Intervention": [{"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Observation": "shorter", "Outcome": "total length of hospitalization", "Count": ""}]}, {"Section": "CONCLUSION", "Text": "Compared with COT , early application of HFNC oxygen therapy in patients with severe COVID-19 can improve oxygenation and RR , and HFNC oxygen therapy can improve the infection indexes of patients and reduce the length of stay in the ICU of patients .", "Evidence Elements": {"Participant": [{"term": "severe COVID-19", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 93}], "Intervention": [{"term": "COT", "negation": "affirmed", "UMLS": {}, "start": 14, "end": 17, "has_procedure": [{"text": "conventional oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 27}], "has_relation": "N/A"}, {"term": "HFNC oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 41, "end": 60, "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}, {"term": "HFNC oxygen therapy", "negation": "affirmed", "UMLS": {}, "start": 41, "end": 60, "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}], "Outcome": [{"term": "oxygenation", "negation": "affirmed", "UMLS": {}, "start": 106, "end": 117}, {"term": "RR", "negation": "affirmed", "UMLS": {}, "start": 122, "end": 124}, {"term": "infection indexes", "negation": "affirmed", "UMLS": {}, "start": 167, "end": 184}, {"term": "length of stay in the ICU", "negation": "affirmed", "UMLS": {}, "start": 212, "end": 237}], "Observation": [{"term": "improve", "negation": "affirmed", "UMLS": {}, "start": 98, "end": 105}, {"term": "improve", "negation": "affirmed", "UMLS": {}, "start": 98, "end": 105}, {"term": "reduce", "negation": "affirmed", "UMLS": {}, "start": 201, "end": 207}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}, "Observation": "improve", "Outcome": "infection indexes", "Count": ""}, {"Intervention": {"term": "HFNC oxygen therapy", "has_procedure": [{"text": "hfnc oxygen therapy", "maps_to": "C0184633:oxygen therapy", "start": 0, "end": 19}], "has_relation": "N/A"}, "Observation": "reduce", "Outcome": "length of stay in the ICU", "Count": ""}]}, {"Section": "CONCLUSION", "Text": "Therefore , it has high clinical application value .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "clinical application", "negation": "affirmed", "UMLS": {}, "start": 24, "end": 44}], "Observation": [{"term": "high", "negation": "affirmed", "UMLS": {}, "start": 19, "end": 23}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "\u00a9 2020 Stichting European Society for Clinical Investigation Journal Foundation . Published by John Wiley & Sons Ltd .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}